2020
|
Invention
|
Deuterated cftr potentiators.
This invention relates to compounds of Formula I:
This invention... |
|
Invention
|
Administration of deuterated cftr potentiators.
Disclosed is a method of treating in a subject o... |
|
Invention
|
Methods of treatment with deuterated cftr potentiators.
Disclosed is a method of treating in a s... |
2019
|
Invention
|
Deuterated cftr potentiators. This invention relates to compounds of Formula I:
and pharmaceuti... |
2018
|
Invention
|
Deuterated cftr modulators. This invention relates to novel, deuterated forms of VX-661 and pharm... |
2017
|
Invention
|
Methods of treatment with deuterated cftr potentiators. Disclosed is a method of treating in a su... |
|
Invention
|
Deuterium-modified cftr modulators.
This invention relates to novel 4,4,5,5,7,7-hexamethyl-5,7-d... |
|
Invention
|
Deuterium-modified cftr modulators. This invention relates to novel 4,4,5,5,7,7-hexamethyl-5,7-di... |
2016
|
Invention
|
Deuterated cftr potentiators. This invention relates to compounds of Formula (I) and pharmaceutic... |
|
Invention
|
Administration of deuterated cftr potentiators. Disclosed is a method of treating in a subject of... |
|
Invention
|
Deuterated vx-661. This invention relates to deuterated compounds of Formula A: , andph... |